Zani, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 552
EU - Europa 203
AS - Asia 107
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
SA - Sud America 1
Totale 869
Nazione #
US - Stati Uniti d'America 549
IT - Italia 88
HK - Hong Kong 41
CN - Cina 29
DE - Germania 24
SG - Singapore 22
FI - Finlandia 21
IE - Irlanda 20
UA - Ucraina 12
GB - Regno Unito 10
PL - Polonia 10
SE - Svezia 10
VN - Vietnam 9
CZ - Repubblica Ceca 5
AU - Australia 3
CA - Canada 3
EU - Europa 2
FR - Francia 2
IN - India 2
TR - Turchia 2
IQ - Iraq 1
LK - Sri Lanka 1
MU - Mauritius 1
NL - Olanda 1
PE - Perù 1
Totale 869
Città #
Fairfield 65
Chandler 63
Seattle 48
Ashburn 43
Hong Kong 41
New York 40
Woodbridge 38
Brescia 34
Cambridge 29
Houston 28
Princeton 26
Wilmington 22
Dublin 20
Helsinki 19
Jacksonville 14
Shanghai 14
Singapore 14
Ann Arbor 12
Warsaw 10
Dong Ket 8
Beijing 7
Munich 7
Boardman 5
Brno 5
Castiglione Delle Stiviere 5
Turin 5
Cagliari 4
Los Angeles 4
Bergamo 3
Chicago 3
Des Moines 3
Glasgow 3
Milan 3
San Diego 3
Udine 3
Gunzenhausen 2
Kilburn 2
Kocaeli 2
Lappeenranta 2
London 2
Redwood City 2
Roebling 2
Shenyang 2
Sydney 2
Toronto 2
Baghdad 1
Brooklyn 1
Civitavecchia 1
Colombo 1
Edmonton 1
Guangzhou 1
Ho Chi Minh City 1
Leawood 1
Lima 1
Margate 1
Nanchang 1
New Bedfont 1
Newark 1
Norwalk 1
Padova 1
Pune 1
Ramacca 1
Scafati 1
Seregno 1
Southwark 1
Tianjin 1
Torrance 1
Tradate 1
Vasto 1
Villa 1
Washington 1
Yerres 1
Zhengzhou 1
Totale 699
Nome #
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 96
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 95
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 86
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 74
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 63
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 56
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 52
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 48
COVID-19: Studi sull'attività replicativa del virus e sull'attività antivirale del metotrexato 46
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 46
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 32
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 27
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 26
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 24
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 22
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 21
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 20
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 16
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 14
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 11
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 10
Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5 5
Totale 890
Categoria #
all - tutte 7.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 3 4 5 9 5 4 13 5 5
2020/2021287 0 5 1 8 0 22 66 94 11 37 19 24
2021/2022128 9 28 5 7 2 6 7 13 7 11 7 26
2022/2023186 15 0 15 10 22 46 1 22 28 2 20 5
2023/2024229 18 4 24 19 8 40 12 13 42 9 12 28
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 890